+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Hyaluronic Acid Market Size, Share & Trends Analysis Report by Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), Region (North America, Europe, Asia-Pacific) with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 150 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 3450702
The Hyaluronic Acid Market was valued at USD 10.73 billion in 2024, and is projected to reach USD 16.7 billion by 2030, rising at a CAGR of 7.81%. Factors, such as increasing concern of population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact rendering drivers. The industry is evolving rapidly due to the increasing adoption of aesthetic procedures in developed and developing regions. Increasing the use of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for improving compatibility coupled with the growing awareness about anti-aging products is fueling the growth.

The efficacy and evident results of hyaluronic acid-based dermal fillers are attracting this population base. Furthermore, the COVID-19 pandemic has changed the dynamics of many industries, with movement restrictions, social distancing, and revised practices becoming the “new normal.” As the cosmetic industry is gradually resuming its operations, a number of doctors have reported a significant increase in inquiries for aesthetic surgeries. Moreover, the lockdown has encouraged all professionals to use video-conferencing facilities, which has made people more conscious of their looks. In some cases, it has led people to opt for cosmetic treatments; this is termed the “Zoom Boom” or the “Zoom effect.”

Cosmetic surgeons across the world have witnessed a significant increase in the number of patients as a result of the pandemic, particularly in countries, such as the U.S., Australia, and Japan. North America held the maximum revenue share in 2022. Preference for short-treatment regimens, even though high-priced, and the prevalence of target diseases, such as osteoarthritis, are the key factors attributed to the high share. In 2022, the most lucrative product applications in the North America region were in the form of dermal fillers and viscos supplements for the management of osteoarthritis. Asia-Pacific is anticipated to register the fastest CAGR during the forecast period.

The growing geriatric population in China and Japan provide a large customer base for anti-aging products and services. Rising awareness about product applications and efficacy also fuels the demand. In addition, increasing disposable income levels are further supporting the region’s expansion. Europe has undergone impressive changes over the last 2 years. The growing demand is witnessing increasing price competition owing to new entrants. The WHO recently announced the obesity epidemic in the U.K. and Germany. The relationship between the increasing aging population and obesity is a potential driver for the Europe regional sector

Hyaluronic Acid Market Report Highlights

  • The dermal fillers segment dominated the market and obtained the largest revenue share of 41.82% in 2024.
  • North America dominated the market and accounted for 42.08% share in 2024. The hyaluronic acid market is driven by increasing demand for anti-aging treatments, rising osteoarthritis cases, and growing awareness of minimally invasive procedures.
  • The U.S. hyaluronic acid market is experiencing robust growth, driven by increasing demand for non-surgical aesthetic procedures and advancements in medical applications, particularly hyaluronic acid-based dermal fillers.
  • APAC hyaluronic acid market is anticipated grow with a CAGR of 8.25% over the forecast period.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. Regional scope
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis
1.8. List of Secondary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Hyaluronic Acid Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis
Chapter 4. Hyaluronic Acid Market: Application Estimates & Trend Analysis
4.1. Application Market Share, 2024 & 2030
4.2. Application Segment Dashboard
4.3. Market Size & Forecasts and Trend Analyses, By Application, 2018 to 2030
4.3.1. Dermal fillers
4.3.1.1. Dermal fillers Market 2018-2030 (USD Million)
4.3.2. Osteoarthritis
4.3.2.1. Osteoarthritis Market 2018 to 2030 (USD Million)
4.3.2.2. Single-injection
4.4.2.2.1 Single injection Market 2018 to 2030 (USD Million)
4.3.2.3. Three-injection
4.4.2.3.1. Three injection Market 2018 to 2030 (USD Million)
4.3.2.4. Five-injection
4.4.2.3.1. Five injection Market 2018 to 2030 (USD Million)
4.4.3. Ophthalmic
4.4.3.3. Ophthalmic Market 2018 to 2030 (USD Million)
4.4.4. Vesicoureteral reflux
4.4.2.3. Vesicoureteral reflux Market 2018 to 2030 (USD Million)
Chapter 5. Hyaluronic Acid Market: Regional Estimates & Trend Analysis
5.1. Regional Market Share Analysis, 2024 & 2030
5.2. Regional Market Dashboard
5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
5.4. North America
5.5.1. North America Hyaluronic Acid Market Estimates And Forecasts, By Country, 2018-2030 (USD Million)
5.5.2. U.S.
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/
5.5.1.3. Reimbursement structure
5.5.1.4. U.S. Hyaluronic Acid market 2018 to 2030 (USD Million)
5.5.3. Canada
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework
5.5.1.3. Reimbursement structure
5.5.1.4. Canada Hyaluronic Acid market 2018 to 2030 (USD Million)
5.5.4. Mexico
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework
5.5.1.3. Reimbursement structure
5.5.1.4. Mexico Hyaluronic Acid market 2018 to 2030 (USD Million)
5.5. Europe
5.5.1. Europe Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.2. UK
5.5.2.1. Key Country Dynamics
5.5.2.2. Regulatory Framework
5.5.2.3. Reimbursement Framework
5.5.2.4. UK Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.3. Germany
5.5.3.1. Key Country Dynamics
5.5.3.2. Regulatory Framework
5.5.3.3. Reimbursement Framework
5.5.3.4. Germany Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.4. France
5.5.4.1. Key Country Dynamics
5.5.4.2. Regulatory Framework
5.5.4.3. Reimbursement Framework
5.5.4.4. France Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.5. Italy
5.5.5.1. Key Country Dynamics
5.5.5.2. Regulatory Framework
5.5.5.3. Reimbursement Framework
5.5.5.4. Italy Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.6. Spain
5.5.6.1. Key Country Dynamics
5.5.6.2. Regulatory Framework
5.5.6.3. Reimbursement Framework
5.5.6.4. Spain Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.7. Denmark
5.5.7.1. Key Country Dynamics
5.5.7.2. Regulatory Framework
5.5.7.3. Reimbursement Framework
5.5.7.4. Denmark Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.8. Sweden
5.5.8.1. Key Country Dynamics
5.5.8.2. Regulatory Framework
5.5.8.3. Reimbursement Framework
5.5.8.4. Sweden Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.9. Norway
5.5.9.1. Key Country Dynamics
5.5.9.2. Regulatory Framework
5.5.9.3. Reimbursement Framework
5.5.9.4. Norway Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Asia Pacific
5.6.1. Asia Pacific Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6.2. Japan
5.6.2.1. Key Country Dynamics
5.6.2.2. Regulatory Framework
5.6.2.3. Reimbursement Framework
5.6.2.4. Japan Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6.3. China
5.6.3.1. Key Country Dynamics
5.6.3.2. Regulatory Framework
5.6.3.3. Reimbursement Framework
5.6.3.4. China Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6.4. India
5.6.4.1. Key Country Dynamics
5.6.4.2. Regulatory Framework
5.6.4.3. Reimbursement Framework
5.6.4.4. India Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6.5. Australia
5.6.5.1. Key Country Dynamics
5.6.5.2. Regulatory Framework
5.6.5.3. Reimbursement Framework
5.6.5.4. Australia Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6.6. South Korea
5.6.6.1. Key Country Dynamics
5.6.6.2. Regulatory Framework
5.6.6.3. Reimbursement Framework
5.6.6.4. South Korea Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6.7. Thailand
5.6.7.1. Key Country Dynamics
5.6.7.2. Regulatory Framework
5.6.7.3. Reimbursement Framework
5.6.7.4. Thailand Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Latin America
5.7.1. Latin America Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7.2. Brazil
5.7.2.1. Key Country Dynamics
5.7.2.2. Regulatory Framework
5.7.2.3. Reimbursement Framework
5.7.2.4. Japan Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7.3. Argentina
5.7.3.1. Key Country Dynamics
5.7.3.2. Regulatory Framework
5.7.3.3. Reimbursement Framework
5.7.3.4. China Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8. Middle East and Africa
5.8.1. Middle East and Africa Hyaluronic Acid Market Estimates and Forecasts, 2017-2030 (USD Million)
5.8.2. South Africa
5.8.2.1. Key Country Dynamics
5.8.2.2. Regulatory Framework
5.8.2.3. Reimbursement Framework
5.8.2.4. South Africa Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8.3. Saudi Arabia
5.8.3.1. Key Country Dynamics
5.8.3.2. Regulatory Framework
5.8.3.3. Reimbursement Framework
5.8.3.4. Saudi Arabia Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8.4. UAE
5.8.4.1. Key Country Dynamics
5.8.4.2. Regulatory Framework
5.8.4.3. Reimbursement Framework
5.8.4.4. UAE Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8.5. Kuwait
5.8.5.1. Key Country Dynamics
5.8.5.2. Regulatory Framework
5.8.5.3. Reimbursement Framework
5.8.5.4. Kuwait Hyaluronic Acid Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Participant Overview
6.2. Company Market Position Analysis
6.3. Company Categorization
6.4. Strategy Mapping
6.5. Company Profiles/Listings
6.5.1. Allergan
6.5.1.1. Company overview
6.5.1.2. Financial performance
6.5.1.3. Product benchmarking
6.5.1.4. Strategic initiatives
6.5.2. Sanofi
6.5.2.1. Company overview
6.5.2.2. Financial performance
6.5.2.3. Product benchmarking
6.5.2.4. Strategic initiatives
6.5.3. Genzyme Corporation
6.5.3.1. Company overview
6.5.3.2. Financial performance
6.5.3.3. Product benchmarking
6.5.3.4. Strategic initiatives
6.5.4. Anika Therapeutics, Inc.
6.5.4.1. Company overview
6.5.4.2. Financial performance
6.5.4.3. Product benchmarking
6.5.4.4. Strategic initiatives
6.5.5. Salix Pharmaceuticals
6.5.5.1. Company overview
6.5.5.2. Financial performance
6.5.5.3. Product benchmarking
6.5.5.4. Strategic initiatives
6.5.6. Seikagaku Corporation
6.5.6.1. Company overview
6.5.6.2. Financial performance
6.5.6.3. Product benchmarking
6.5.6.4. Strategic initiatives
6.5.7. F. Hoffmann-La Roche Ag
6.5.7.1. Company overview
6.5.7.2. Financial performance
6.5.7.3. Product benchmarking
6.5.7.4. Strategic initiatives
6.5.8. Galderma Laboratories L.P.
6.5.8.1. Company overview
6.5.8.2. Financial performance
6.5.8.3. Product benchmarking
6.5.8.4. Strategic initiatives
6.5.9. Zimmer Biomet
6.5.9.1. Company overview
6.5.9.2. Financial performance
6.5.9.3. Product benchmarking
6.5.9.4. Strategic initiatives
6.5.10. Smith & Nephew Plc
6.5.10.1. Company overview
6.5.10.2. Financial performance
6.5.10.3. Product benchmarking
6.5.10.4. Strategic initiatives
6.5.11. Ferring B.V.
6.5.11.1. Company overview
6.5.11.2. Financial performance
6.5.11.3. Product benchmarking
6.5.11.4. Strategic initiatives
6.5.12. Lifecore Biomedical, Llc
6.5.12.1. Company overview
6.5.12.2. Financial performance
6.5.12.3. Product benchmarking
6.5.12.4. Strategic initiatives
6.5.13. HTL Biotechnology
6.5.13.1. Company overview
6.5.13.2. Financial performance
6.5.13.3. Product benchmarking
6.5.13.4. Strategic initiatives
6.5.14. Shiseido Company, Limited
6.5.14.1. Company overview
6.5.14.2. Financial performance
6.5.14.3. Product benchmarking
6.5.14.4. Strategic initiatives
6.5.15. Bloomage Biotechnology Corporation Limited
6.5.15.1. Company overview
6.5.15.2. Financial performance
6.5.15.3. Product benchmarking
6.5.15.4. Strategic initiatives
6.5.16. LG Life Sciences Ltd (LG Chem.)
6.5.16.1. Company overview
6.5.16.2. Financial performance
6.5.16.3. Product benchmarking
6.5.16.4. Strategic initiatives
6.5.17. Maruha Nichiro, Inc.
6.5.17.1. Company overview
6.5.17.2. Financial performance
6.5.17.3. Product benchmarking
6.5.17.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global hyaluronic acid market, by region, 2018-2030 (USD Million)
Table 4 Global hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 5 North America hyaluronic acid market, by country, 2018-2030 (USD Million)
Table 6 North America hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 7 U.S. hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 8 Canada hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 9 Mexico hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 10 Europe hyaluronic acid market, by country, 2018-2030 (USD Million)
Table 11 Europe hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 12 UK hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 13 Germany hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 14 France hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 15 Italy hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 16 Spain hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 17 Norway hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 18 Denmark hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 19 Sweden hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 20 Asia Pacific hyaluronic acid market, by country, 2018-2030 (USD Million)
Table 21 Asia Pacific hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 22 Japan hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 23 China hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 24 India hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 25 Australia hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 26 South Korea hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 27 Thailand hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 28 Latin America hyaluronic acid market, by country, 2018-2030 (USD Million)
Table 29 Latin America hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 30 Brazil hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 31 Argentina hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 32 Middle East & Africa Docetaxel market, by country, 2018-2030 (USD Million)
Table 33 Middle East & Africa hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 34 South Africa hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 35 Saudi Arabia hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 36 UAE hyaluronic acid market, by application, 2018-2030 (USD Million)
Table 37 Kuwait hyaluronic acid market, by application, 2018-2030 (USD Million)
List of Figures
Figure 1 Hyaluronic Acid market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Therapeutic approach and application outlook (USD Million)
Figure 10 Competitive landscape
Figure 11 Hyaluronic Acid market dynamics
Figure 12 Hyaluronic Acid market: Porter’s five forces analysis
Figure 13 Hyaluronic Acid market: PESTLE analysis
Figure 14 Product market, 2018-2030 (USD Million)
Figure 15 Dermal fillers market, 2018-2030 (USD Million)
Figure 16 Osteoarthritis market, 2018-2030 (USD Million)
Figure 17 Ophthalmic market, 2018-2030 (USD Million)
Figure 18 Vesicoureteral reflux market, 2018-2030 (USD Million)
Figure 19 Regional marketplace: Key takeaways
Figure 20 North America hyaluronic acid market, 2018-2030 (USD Million)
Figure 21 U.S. country dynamics
Figure 22 U.S. hyaluronic acid market, 2018-2030 (USD Million)
Figure 23 Canada country dynamics
Figure 24 Canada hyaluronic acid market, 2018-2030 (USD Million)
Figure 25 Mexico country dynamics
Figure 26 Mexico hyaluronic acid market, 2018-2030 (USD Million)
Figure 27 Europe hyaluronic acid market, 2018-2030 (USD Million)
Figure 28 UK country dynamics
Figure 29 UK hyaluronic acid market, 2018-2030 (USD Million)
Figure 30 Germany country dynamics
Figure 31 Germany hyaluronic acid market, 2018-2030 (USD Million)
Figure 32 France country dynamics
Figure 33 France hyaluronic acid market, 2018-2030 (USD Million)
Figure 34 Italy country dynamics
Figure 35 Italy hyaluronic acid market, 2018-2030 (USD Million)
Figure 36 Spain country dynamics
Figure 37 Spain hyaluronic acid market, 2018-2030 (USD Million)
Figure 38 Norway country dynamics
Figure 39 Norway hyaluronic acid market, 2018-2030 (USD Million)
Figure 40 Sweden country dynamics
Figure 41 Sweden hyaluronic acid market, 2018-2030 (USD Million)
Figure 42 Denmark country dynamics
Figure 43 Denmark hyaluronic acid market, 2018-2030 (USD Million)
Figure 44 Asia Pacific hyaluronic acid market, 2018-2030 (USD Million)
Figure 45 Japan country dynamics
Figure 46 Japan hyaluronic acid market, 2018-2030 (USD Million)
Figure 47 China country dynamics
Figure 48 China hyaluronic acid market, 2018-2030 (USD Million)
Figure 49 India country dynamics
Figure 50 India hyaluronic acid market, 2018-2030 (USD Million)
Figure 51 Australia country dynamics
Figure 52 Australia hyaluronic acid market, 2018-2030 (USD Million)
Figure 53 South Korea country dynamics
Figure 54 South Korea hyaluronic acid market, 2018-2030 (USD Million)
Figure 55 Thailand country dynamics
Figure 56 Thailand hyaluronic acid market, 2018-2030 (USD Million)
Figure 57 Latin America hyaluronic acid market, 2018-2030 (USD Million)
Figure 58 Brazil country dynamics
Figure 59 Brazil hyaluronic acid market, 2018-2030 (USD Million)
Figure 60 Argentina country dynamics
Figure 61 Argentina hyaluronic acid market, 2018-2030 (USD Million)
Figure 62 MEA hyaluronic acid market, 2018-2030 (USD Million)
Figure 63 South Africa country dynamics
Figure 64 South Africa hyaluronic acid market, 2018-2030 (USD Million)
Figure 65 Saudi Arabia country dynamics
Figure 66 Saudi Arabia hyaluronic acid market, 2018-2030 (USD Million)
Figure 67 UAE country dynamics
Figure 68 UAE hyaluronic acid market, 2018-2030 (USD Million)
Figure 69 Kuwait country dynamics
Figure 70 Kuwait hyaluronic acid market, 2018-2030 (USD Million)
Figure 71 Company categorization
Figure 72 Company market position analysis
Figure 73 Strategic framework

Companies Mentioned

The major companies featured in this Hyaluronic Acid market report include:
  • Allergan
  • Sanofi
  • Genzyme Corporation
  • Salix Pharmaceuticals
  • F. Hoffmann-La Roche Ag
  • Galderma Laboratories L.P.
  • Zimmer Biomet
  • Smith & Nephew Plc
  • Ferring B.V.
  • Lifecore Biomedical, Llc
  • HTL Biotechnology
  • Shiseido Company, Limited
  • Bloomage Biotechnology Corporation Limited
  • LG Life Sciences Ltd (LG Chem.)
  • Maruha Nichiro, Inc.

Table Information